Academic Journal
P021 SUBCUTANEOUS CERTOLIZUMAB PEGOL IS WELL TOLERATED BY PATIENTS WITH ACTIVE CROHN'S DISEASE: RESULTS FROM TWO PHASE III STUDIES (PRECISE 1 AND 2)
| العنوان: | P021 SUBCUTANEOUS CERTOLIZUMAB PEGOL IS WELL TOLERATED BY PATIENTS WITH ACTIVE CROHN'S DISEASE: RESULTS FROM TWO PHASE III STUDIES (PRECISE 1 AND 2) |
|---|---|
| المؤلفون: | Schreiber, S., Feagan, B.G., Hanauer, S.B., Rutgeerts, P., Sandborn, W.J. |
| المصدر: | Journal of Crohn's and Colitis Supplements ; volume 1, issue 1, page 9 ; ISSN 1873-9954 |
| بيانات النشر: | Oxford University Press (OUP) |
| سنة النشر: | 2007 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s1873-9954(07)70033-2 |
| الاتاحة: | https://doi.org/10.1016/s1873-9954(07)70033-2 http://api.elsevier.com/content/article/PII:S1873995407700332?httpAccept=text/xml http://api.elsevier.com/content/article/PII:S1873995407700332?httpAccept=text/plain http://academic.oup.com/ecco-jccs/article-pdf/1/1/9/7098991/1-1-9a.pdf |
| رقم الانضمام: | edsbas.DC148DDF |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s1873-9954(07)70033-2 |
|---|